Shopping Cart
- Remove All
- Your shopping cart is currently empty
NV03 is a potent and selective antagonist of the UHRF1 (Ubiquitin-like with PHD and RING finger domains 1)-H3K9me3 interaction, binding to the UHRF1 tandem tudor domain with a Kd of 2.4 μM. NV03 holds potential as an anticancer therapeutic [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,650 | 6-8 weeks | |
50 mg | $2,150 | 6-8 weeks | |
100 mg | $3,480 | 6-8 weeks |
Description | NV03 is a potent and selective antagonist of the UHRF1 (Ubiquitin-like with PHD and RING finger domains 1)-H3K9me3 interaction, binding to the UHRF1 tandem tudor domain with a Kd of 2.4 μM. NV03 holds potential as an anticancer therapeutic [1]. |
Molecular Weight | 389.52 |
Formula | C19H27N5O2S |
Cas No. | 2448341-58-8 |
Relative Density. | 1.29 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.